| Chagas disease JA Pérez-Molina, I Molina The Lancet 391 (10115), 82-94, 2018 | 1401 | 2018 |
| False-negative results of initial RT-PCR assays for COVID-19: a systematic review I Arevalo-Rodriguez, D Buitrago-Garcia, D Simancas-Racines, ... PloS one 15 (12), e0242958, 2020 | 799 | 2020 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 485 | 2021 |
| Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial CA Morillo, H Waskin, S Sosa-Estani, M del Carmen Bangher, C Cuneo, ... Journal of the American College of Cardiology 69 (8), 939-947, 2017 | 300 | 2017 |
| Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection C Henriquez‐Camacho, E Gotuzzo, J Echevarria, AC White Jr, ... Cochrane Database of Systematic Reviews, 2016 | 267 | 2016 |
| Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ... PloS one 9 (1), e85798, 2014 | 261 | 2014 |
| Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis JA Pérez-Molina, A Pérez-Ayala, S Moreno, MC Fernandez-Gonzalez, ... Journal of Antimicrobial Chemotherapy 64 (6), 1139-1147, 2009 | 236 | 2009 |
| Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. R Lopez-Velez, JA Perez-Molina, A Guerrero, F Baquero, J Villarrubia, ... The American journal of tropical medicine and hygiene 58 (4), 436-443, 1998 | 181 | 1998 |
| Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos (t) ides in virologically stable patients with HIV-1 … JA Perez-Molina, R Rubio, A Rivero, J Pasquau, I Suárez-Lozano, ... The Lancet Infectious Diseases 15 (7), 775-784, 2015 | 175 | 2015 |
| Old and new challenges in Chagas disease JA Pérez-Molina, AM Perez, FF Norman, B Monge-Maillo, R López-Vélez The Lancet infectious diseases 15 (11), 1347-1356, 2015 | 162 | 2015 |
| Short-Course Therapy for Right-Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin J Fortún, E Navas, J Martínez-Beltrán, J Perez-Molina, P Martín-Dávila, ... Clinical Infectious Diseases 33 (1), 120-125, 2001 | 159 | 2001 |
| Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients JA Pérez-Molina HIV clinical trials 3 (4), 279-286, 2002 | 133 | 2002 |
| Imported infectious diseases in mobile populations, Spain B Monge-Maillo, BC Jiménez, JA Pérez-Molina, F Norman, M Navarro, ... Emerging infectious diseases 15 (11), 1745, 2009 | 131 | 2009 |
| Chagas disease in Latin American migrants: a Spanish challenge A Pérez-Ayala, JA Pérez-Molina, F Norman, M Navarro, B Monge-Maillo, ... Clinical microbiology and infection 17 (7), 1108-1113, 2011 | 120 | 2011 |
| Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment JA Pérez-Molina, F Norman, R López-Vélez Current infectious disease reports 14, 263-274, 2012 | 119 | 2012 |
| Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study J Martínez-Sanz, A Muriel, R Ron, S Herrera, JA Pérez-Molina, S Moreno, ... Clinical Microbiology and Infection 27 (2), 238-243, 2021 | 110 | 2021 |
| Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge B Monge-Maillo, R López-Vélez, FF Norman, F Ferrere-González, ... The American Journal of Tropical Medicine and Hygiene 92 (4), 848, 2015 | 102 | 2015 |
| Workload Due to Aspergillus fumigatus and Significance of the Organism in the Microbiology Laboratory of a General Hospital E Bouza, J Guinea, T Pelaez, J Perez-Molina, L Alcala, P Munoz Journal of clinical microbiology 43 (5), 2075-2079, 2005 | 100 | 2005 |
| Report of ESGNI‐001 and ESGNI‐002 studies. Bloodstream infections in Europe E Bouza, J Pérez‐Molina, P Munoz, ... Clinical microbiology and infection 5, 2s1-2s12, 1999 | 99 | 1999 |
| Correlation between the Elastase Activity Index and Invasiveness of Clinical Isolates of Aspergillus fumigatus JL Blanco, R Hontecillas, E Bouza, I Blanco, T Pelaez, P Muñoz, ... Journal of clinical microbiology 40 (5), 1811-1813, 2002 | 98 | 2002 |
